ACE and IgA glomerulonephritis: In addition, there is another report that showed the efficacy of IVCY (500–750 mg m−2 once a month for 1–6 months) combined with corticosteroids, and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker for pediatric patients with severe HSPN and IgA nephropathy [4].